Japan could become one of the first countries in the world to end the HIV epidemic, says the president of Gilead Sciences Japan, Kennet Brysting. The idea for now could seem a little too ambitious, ...

Shionogi now plans to accelerate its expansion in Europe and the U.S., while pursuing full-scale growth of its new drug ...

TOKYO, Dec 6 (Reuters) - Japan Tobacco Inc said on Thursday it has applied to sell an anti-HIV drug treatment in Japan. If approved by the Health Ministry, it would be the only once-daily ...

TOKYO (Reuters) - Japan plans to start trials of HIV medications to treat coronavirus patients as an increase in the number of cases poses a growing threat to the economy and public health, the ...

A research group led by Professor Wei Li from the Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Toho University, in collaboration with the Duke University Medical Center in the ...

The first in-human trial of a CRISPR Cas system delivered by adeno-associated virus 9 gene therapy to treat HIV was able to target only the intended DNA and cleared the blood within 6 months.